Mucosal and systemic immunity to bovine herpesvirus-1 glycoprotein D confer resistance to viral replication and latency in cattle

Vaccine

Volumn 14, Issue 1, 1996, Pages 61-69

  Zhu, Xiaoping ^a   Letchworth III, Geoffrey J ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Bovine herpesvirus 1; CTB; Glycoprotein D; Latency; Mucosal immunity; Protection

Indexed keywords

GLYCOPROTEIN D; HERPES VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BOVINE HERPES VIRUS; CATTLE; HOST RESISTANCE; MALE; MUCOSA; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0030067232     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00123-I     Document Type: Article

References (46)

1. Wyler, R., Engels, M. and Schwyzer, M. Infectious bovine rhinotracheitis/vulvovaginitis. In: Herpesvirus Disease of Cattle, Horses and Pigs. Developments in Veterinary Virology (Ed. Wittmann, G.). Kluwer Academic Publishers, Boston, 1989, pp. 1-72
2. Yates, W.D.G. A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease in cattle. Can. J. Comp. Med. 1982, 46, 225-263
3. Israel, B.A., Marshall, R.L. and Letchworth, G.J. Epitope specificity and protective efficiency of the bovine immune response to bovine herpesvirus-1 glycoprotein vaccines. Vaccine 1988, 6, 349-356
4. Whetstone, C.A., Wheeler, J.G. and Reed, D.E. Investigation of possible vaccine-induced epizootic of infectious bovine rhinotracheitis, using restriction endonuclease analysis of viral DNA. Am. J. Vet. Res. 1986, 47, 1789-1795
5. Mitchell, A. An outbreak of abortion in a dairy herd following inoculation with an intramuscular infectious bovine rhinotracheitis vaccine. Can. Vet. J. 1974, 15, 148-151
6. Pastoret, P.P., Babiuk, L.A., Misra, V. and Griebel, P. Reactivation of temperature-sensitive and non-temperature-sensitive infectious bovine rhinotracheitis with dexamethasone. Infect. Immun. 1980, 29, 483-488
7. Thiry, E., Brouchier, B., Saliki, J., Pirak, M. and Pastoret, P.P. Excretion and reexcretion of thermosensitive and wild type strains of infectious bovine rhinotracheitis virus after co-infection or two successive infectious. Vet. Microbiol. 1985, 10, 371-380
8. Oldstone, M.B.A., Tishon, A., Eddleston, M., Torre, J.C., McKee, T. and Whitton, J.L. Vaccination to prevent persistent viral infection. J. Virol. 1993, 67, 4372-4378
9. Israel, B.A., Herber, R., Gao, Y. and Letchworth, G.J. Induction of a mucosal barrier to herpesvirus 1 replication in cattle. Virology 1992, 188, 256-264
10. Misra, V., Blumenthal, R.M. and Babiuk, L.A. Proteins specified by bovine herpesvirus 1 (infectious bovine rhinotracheitis virus). J. Virol. 1981, 40, 367-378
11. Marshall, R.L., Rodriguez, L.L. and Letchworth III, G.J. Characterization of envelope proteins of infectious bovine rhinotracheitis virus (bovine herpesvirus 1) by biochemical and immunological methods. J. Virol. 1986, 57, 745-753
12. Hughes, G., Babiuk, L.A. and van Drunen Littel-van den Hurk, S. Functional and topographical analysis of epitopes on bovine herpesvirus type 1 glycoprotein IV. Arch. Virol. 1988, 103, 47-60
13. Liang, X., Babiuk, L.A., van Drunen Littel-van den Hurk, S., Fitzpatrick, D.R. and Zamb, T.J. Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV. J. Virol. 1991, 65, 1124-1132
14. Dubuisson, J., Israel, B.A. and Letchworth, G.J. Mechanism of bovine herpesvirus type 1 neutralization by monoclonal antibodies to glycoproteins gI, gIII and gIV. J. Gen. Virol. 1992, 73, 2031-2039
15. Van Drunen Littel-van den Hurk, S., van den Hurk, J.V. and Babiuk, L.A. Topographical analysis of bovine herpesvirus type 1 glycoproteins: use of monoclonal antibodies to identify and characterize functional epitopes. Virology 1985, 144, 216-227
16. Marshall, R.L., Israel, B.A. and Letchworth III, G.J. Monoclonal antibody analysis of bovine herpesvirus 1 glycoprotein antigenic areas relevant to natural infection. Virology 1988, 165, 338-347
17. Tamura, S., Samegai, Y., Kurata, H., Kikuta, K., Nagamine, T., Aizawa, C. and Kurtata, T. Enhancement of protective antibody response by cholera toxin B subunit inoculated intranasally with influenza vaccine. Vaccine 1989, 7, 257-262
18. Nedrud, J.G., Liang, X., Hague, N. and Lamm, M.E. Combined oral/nasal immunization protects mice from Sendai virus infection. J. Immunol. 1987, 139, 3484-3492
19. Van Drunen Littel-van den Hurk, S., van den Hurk, J.V., Gilchrist, J.E., Misra, V. and Babiuk, L.A. Interactions of monoclonal antibodies and bovine herpesvirus type 1 (BHV-1) glycoproteins: characterization of their biochemical and immunological properties. Virology 1984, 135, 466-479
20. Srikumaran, S., Goldsby, R.A., Guidry, A.J., Hague, B., Onisk, D.V. and Srikumaran, P. Library of monoclonal bovine immunoglobulins and monoclonal antibodies to bovine immunoglobulins. Hybridoma 1987, 6, 527-530
21. Tikoo, S.K., Fitzpatrick, D.R., Babiuk, L.A. and Zamb, T.J. Molecular cloning, sequencing, and expression of functional bovine herpesvirus 1 glycoprotein gIV in transfected bovine cells. J. Virol. 1990, 64, 5132-5142
22. Van Drunen Littel-van den Hurk, S. and Babiuk, L.A. Synthesis and processing of bovine herpesvirus-1 glycoproteins. J. Virol. 1986, 59, 401-410
23. McGhee, J.R., Mestecky, J., Dertzbaugh, M.T., Eldridge, J.H., Hirasawa, M. and Kiyono, H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992, 10, 75-78
24. Renegar, K.B. and Small, P.A. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J. Virol. 1991, 65, 2146-2148
25. Renegar, K.B. and Small, P.A. Passive transfer of local immunity to influenza virus infection by IgA antibody. J. Immunol. 1991, 146, 1972-1978
26. Mazanec, M.B., Nedrud, J.G., Kaetzel, C.S., Lamm, M.E. A three-tiered view of the role of IgA in mucosal defense. Immunol. Today 1993, 14, 430-435
27. Lehner, T., Bergmeier, L.A., Panagiotidi, C. et al. Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 1992, 258, 1365-1369
28. Gallichan, W.S., Johnson, D.C., Graham, F.L. and Rosenthal, K.L. Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B. J. Infect. Dis. 1993, 168, 622-629
29. Fehler, F., Herrmann, J.M., Saalmuller, A., Mettenleiter, T.C. and Keil, G.M. Glycoprotein IV of bovine herpesvirus 1-expressing cell line complements and rescues a conditionally lethal viral mutant. J. Virol. 1992, 66, 831-839
30. Babiuk, L.A., L'ltalien, J., van Drunen Littel-van den Hurk, S. et al. Protection of cattle from bovine herpesvirus type-1 (BHV-1) infection by immunization with individual glycoproteins. Virology 1987, 159, 57-66
31. Van Drunen Littel-van den Hurk, S., Parker, M.D., Massie, B. et al. Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. Vaccine 1993, 11, 25-35
32. Butler, J.E. Concept of humoral immunity among ruminants and a approach to its investigation. In: The Ruminant Immune System (Ed. Bulter, J.E.). Plenum, New York, 1981, pp. 3-55
33. Rock, D., Lokensgard, J., Lewis, T. and Kutish, G. Characterization of dexamethasone-induced reactivation of latent bovine herpesvirus 1. J. Virol. 1992, 66, 2484-2490
34. Marshall, R.L. and Letchworth III, G.J. Passively administered neutralizing monoclonal antibodies do not protect calves against bovine herpesvirus 1 infection. Vaccine 1988, 6, 343-348
35. Ghasi, H., Kaiwar, R., Nesburn, A.B., Slanina, S. and Wechsler, S.L. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J. Virol. 1994, 68, 2118-2126
36. Liang, X., Lamm, M.E. and Nedrud, J.G. Oral administration of cholera toxin-Sendai virus conjugate potentiate gut and respiratory immunity against Sendai virus. J. Immunol. 1988, 141, 1495-1501
37. Marx, P.A., Compans, R.W., Gettie, J.K. et al. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 1993, 260, 1323-1327
38. Holugren, J., Lycke, N. and Czerkinsky, C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 1993, 11, 1179-1184
39. Lycke, N.Y. Cholera toxin promotes B cell isotype switching by two different mechanisms: cAMP induction augments germ-line Ig H-chain RNA transcripts whereas membrane ganglioside GM-1-receptor binding enhances late events in differentiation. J. Immunol. 1993, 150, 4810-4821
40. Tamura, S.-I., Yamanaka, A., Shimohara, M. et al. Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 1994, 12, 419-426
41. Wilson, A.D., Robinson, A., Irons, L. and Stokes, C.R. Adjuvant action of cholera toxin and pertussis toxin in the induction of IgA antibody response to orally administered antigen. Vaccine 1993, 11, 113-121
42. Gehrz, R.C., Fuad, S., Liu, Y.-N.C. and Bach, F.H. HLA class II restriction of T helper cell response to cytomegalovirus (CMV). I. Immunogenetic control of restriction. J. Immunol. 1987, 138, 3145-3151
43. Curtsinger, J.M., Liu, Y.-N.C., Radeke, R. et al. Molecular analysis of the immune response to human cytomegalovirus glycoprotein B (gB). II. Low gB-specific T and B cell responses are associated with expression of certain HLA-DR alleles. J. Gen. Virol. 1994, 75, 301-307
44. Glass, E.J., Oliver, R.A. and Spooner, R.L. Variation in T cell responses to ovalbumin in cattle: evidence for Ir gene control. Anim. Genet. 1990, 21, 15-25
45. Glass, E.J., Oliver, R.A. and Spooner, R.L. Bovine T cells recognize antigen in association with MHC class II haplotypes defined by one-dimensional isoelectric focusing. Immunology 1991, 72, 380-385
46. Shvartsman, Y.S. and Zykov, M.P. Secretory anti-influenza immunity. Adv. Immunol. 1976, 22, 291-330